What’s been going on in the life sciences world this week? Check out Week in Brief for an overview of the biggest news.

AI holds immense promise in accelerating drug discovery and development—but the journey from data to therapeutic impact is far from straightforward. Despite revolutionary breakthroughs, challenges ...

Currently, Illumina is comfortably the largest gene-sequencing company. But how did Illumina manage to monopolise the gene-sequencing market?

A multi-omics approach involves the combining of different “omics”: genomics, epigenomics, transcriptomics, and proteomics. The simultaneous study of each “omic” can provide a more accurate, holistic, ...

The majority of single-cell analysis studies focus on nucleic acids. The central dogma of molecular biology states that DNA is transcribed into RNA and RNA is translated into proteins, which are the ...

This webinar will demonstrate how variant interpretation software can improve the accuracy and speed of variant interpretation using specific case studies.

The United Arab Emirates (UAE) is investing heavily in its health sector, particularly in genomic medicine, so read on to learn more.

In our latest feature, we explore the future of gene editing and the challenges we must overcome to harness its full potential.

The science of tardigrades has come a long way in the last couple of decades – and their genomes are key to unravelling the mystery.

With all the excitement around multi-omics, there’s one question that stands out … How will multi-omics change healthcare?

TIGER enhances precision in RNA-targeting CRISPR agents, enabling gene expression modulation and the development of new therapies.